Pharmacological effects and clinical applications of ultra low molecular weight heparins.

Liu Z, Ji SL, Sheng JZ, Wang FS

Drug Discov Ther. 2014; 8(1):1-10.

Summary Full Text (PDF)

Design, synthesis and biological evaluation of naphthalimide-based fluorescent probes for α1-adrenergic receptors.

Zhang W, Chen LZ, Ma Z, Du LP, Li MY

Drug Discov Ther. 2014; 8(1):11-17.

Summary Full Text (PDF)

Antioxidant activity of Rafflesia kerrii flower extract.

Puttipan R, Okonogi S

Drug Discov Ther. 2014; 8(1):18-24.

Summary Full Text (PDF)

The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC^Min/+ mice.

Wang RQ, Wang Y, Gao ZH, Qu XJ

Drug Discov Ther. 2014; 8(1):25-32.

Summary Full Text (PDF)

Combination treatment of ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer through inhibition of the EGFR/PI3K/Akt survival pathway and induction of apoptosis.

Chen JH, Wang WF, Wang HY, Liu XY, Guo XL

Drug Discov Ther. 2014; 8(1):33-41.

Summary Full Text (PDF)

Fibroblast growth factor-2 inhibits mineralization of osteoblast-like Saos-2 cells by inhibiting the functioning of matrix vesicles.

Liu C, Cui YZ, Luan J, Zhou XY, Liu ZX, Han JX

Drug Discov Ther. 2014; 8(1):42-47.

Summary Full Text (PDF)

A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: Safety report of the UFT/LV study.

Saiura A, Yamamoto J, Hasegawa K, Oba M, Takayama T, Miyagawa S, Ijichi M, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Makuuchi M, Kokudo N

Drug Discov Ther. 2014; 8(1):48-56.

Summary Full Text (PDF)

A lesson from Japan: Research and development efficiency is a key element of pharmaceutical industry consolidation process.

Shimura H, Masuda S, Kimura H

Drug Discov Ther. 2014; 8(1):57-63.

Summary Full Text (PDF)